The G(1) cyclins, cyclin D1 and E, are rate limiting for progression t
hrough G(1) phase of the cell cycle in breast epithelial cells and are
oncogenic when expressed in the mammary epithelium of transgenic mice
. These genes are frequently overexpressed in clinical breast cancer w
here overexpression appears to be associated with specific disease phe
notypes, altered responsiveness to therapeutic intervention and patien
t survival. In order to investigate the functional correlates of cycli
n D1 and cyclin E overexpression we employed a panel of normal, immort
alized and neoplastic breast epithelial cell lines to examine the rela
tionships between cyclin gene expression, cyclin-CDK complex formation
and CDK activity. In agreement with earlier studies cyclin D1 and E e
xpression varied over an approximately tenfold range among the 18 cell
lines studied. There was no apparent relationship, however, between c
yclin D1 expression and the in vitro activity of its major kinase part
ner, Cdk4, although MDA-MB-134 cells displayed the highest level of bo
th cyclin D1 expression and Cdk4 activity. Similarly, there was no sig
nificant relationship between cyclin E expression and cyclin E-Cdk2 ac
tivity. Fractionation of whole cell lysates by gel filtration chromato
graphy revealed that similar to 90% of the cyclin E protein was presen
t in inactive complexes containing the CDK inhibitors p21 and p27. Muc
h of the small fraction of active cyclin E protein was of very high ap
parent molecular mass, >400 kDa, suggesting that formation of these co
mplexes is a more important determinant of cyclin E-Cdk2 activity than
cyclin E abundance. These data suggest that properties of cyclins D1
and E in addition to their ability to activate Cdk4 and Cdk2 may contr
ibute to the effects of overexpression on the breast cancer phenotype.